IMPRIMIS SHUGARCAINE Trademark

Trademark Overview

On Friday, June 8, 2018, a trademark application was filed for IMPRIMIS SHUGARCAINE with the United States Patent and Trademark Office. The USPTO has given the IMPRIMIS SHUGARCAINE trademark a serial number of 87954133. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 7, 2020. This trademark is owned by IMPRIMIS PHARMACEUTICALS, INC.. The IMPRIMIS SHUGARCAINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ophthalmological applications
imprimis shugarcaine

General Information

Serial Number87954133
Word MarkIMPRIMIS SHUGARCAINE
Filing DateFriday, June 8, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Goods and ServicesPharmaceutical compositions for ophthalmological applications

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHARROW IP, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressNASHVILLE, TN 37205
Party NameHARROW HEALTH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameHARROW HEALTH, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, December 7, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 7, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 1, 2020EXTENSION 1 GRANTED
Friday, May 1, 2020EXTENSION 1 FILED
Friday, May 1, 2020TEAS EXTENSION RECEIVED
Wednesday, November 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 19, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 19, 2019ASSIGNED TO LIE
Monday, July 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2019NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2019NON-FINAL ACTION WRITTEN
Thursday, March 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 12, 2018ASSIGNED TO EXAMINER
Tuesday, October 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 2, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 2, 2018NON-FINAL ACTION WRITTEN
Wednesday, September 26, 2018ASSIGNED TO EXAMINER
Thursday, June 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 12, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

shugarcaine imprimis applications ophthalmological compositions pharmaceutical